Cardiac MRI-confirmed mesalamine-induced myocarditis
نویسندگان
چکیده
منابع مشابه
Mesalamine-Induced Myocarditis
Nowadays mesalamine is a common treatment for Crohn's disease and hypersensitive reactions to this product have been reported. Yet there is limited information concerning mesalamine-induced myocarditis and its mechanism is not known. We described a case of mesalamine-induced myocarditis in Crohn's disease of the colon.
متن کاملCardiac MRI findings in patients with Myocarditis
Methods Patients who underwent CMR at ICPS who were diagnosed with myocarditis on the basis of cardiac imaging and clinical findings (patients, n = 187) between November 2009 and September 2010 were identified through the use of the cardiology database. All patients underwent a similar protocol to look for: 1. LV and RV function 2. The presence of pleural effusion 2. Tissue edema, as seen by an...
متن کاملMyocarditis and colchicine: a new perspective from cardiac MRI
Background Because of anatomic proximity, myocarditis is often associated with pericarditis. Although randomized trials have not delineated a successful evidence-based therapy for myocarditis, there is evidence of considerable benefit in treating pericarditis with a regimen of colchicine and a non-steroidal anti-inflammatory drug (NSAID). Cardiac MRI (CMR) is capable of detecting both myocardit...
متن کاملMesalamine-Induced Myocarditis and Coronary Vasculitis in a Pediatric Ulcerative Colitis Patient: A Case Report
Mesalamine-containing products are often a first-line treatment for ulcerative colitis. Severe adverse reactions to these products, including cardiovascular toxicity, are rarely seen in pediatric patients. We present a case of a 16-year-old boy with ulcerative colitis treated with Asacol, a mesalamine-containing product, who developed sudden onset chest pain after four weeks on therapy. Serial ...
متن کاملMesalamine-induced myocarditis following diagnosis of Crohn's disease: a case report.
Mesalamine is a common treatment for Crohn's disease, and can be rarely associated with myocarditis through a mechanism of drug hypersensitivity. We present the case of a 19-year-old male who developed chest pain two weeks after beginning mesalamine therapy. The electrocardiogram showed slight ST-segment elevation with upward concavity in the inferolateral leads; blood tests demonstrated elevat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ Case Reports
سال: 2015
ISSN: 1757-790X
DOI: 10.1136/bcr-2015-210689